IFITM3 found to be critical regulator of immunotherapy sensitivity in small cell lung cancer
New research presented identifies interferon-induced transmembrane protein 3 (IFITM3) as a critical regulator of immunotherapy sensitivity in small cell lung cancer (SCLC), offering a promising